Literature DB >> 29325072

Sensitive and specific post-call filtering of genetic variants in xenograft and primary tumors.

Brian K Mannakee1,2, Uthra Balaji3, Agnieszka K Witkiewicz2,4,5, Ryan N Gutenkunst6, Erik S Knudsen2,4.   

Abstract

Motivation: Tumor genome sequencing offers great promise for guiding research and therapy, but spurious variant calls can arise from multiple sources. Mouse contamination can generate many spurious calls when sequencing patient-derived xenografts. Paralogous genome sequences can also generate spurious calls when sequencing any tumor. We developed a BLAST-based algorithm, Mouse And Paralog EXterminator (MAPEX), to identify and filter out spurious calls from both these sources.
Results: When calling variants from xenografts, MAPEX has similar sensitivity and specificity to more complex algorithms. When applied to any tumor, MAPEX also automatically flags calls that potentially arise from paralogous sequences. Our implementation, mapexr, runs quickly and easily on a desktop computer. MAPEX is thus a useful addition to almost any pipeline for calling genetic variants in tumors. Availability and implementation: The mapexr package for R is available at https://github.com/bmannakee/mapexr under the MIT license. Contact: mannakee@email.arizona.edu or rgutenk@email.arizona.edu or eknudsen@email.arizona.edu. Supplementary information: Supplementary data are available at Bioinformatics online.

Entities:  

Mesh:

Year:  2018        PMID: 29325072      PMCID: PMC5946891          DOI: 10.1093/bioinformatics/bty010

Source DB:  PubMed          Journal:  Bioinformatics        ISSN: 1367-4803            Impact factor:   6.937


  33 in total

Review 1.  Massively parallel sequencing and rare disease.

Authors:  Sarah B Ng; Deborah A Nickerson; Michael J Bamshad; Jay Shendure
Journal:  Hum Mol Genet       Date:  2010-09-15       Impact factor: 6.150

2.  The Genome Analysis Toolkit: a MapReduce framework for analyzing next-generation DNA sequencing data.

Authors:  Aaron McKenna; Matthew Hanna; Eric Banks; Andrey Sivachenko; Kristian Cibulskis; Andrew Kernytsky; Kiran Garimella; David Altshuler; Stacey Gabriel; Mark Daly; Mark A DePristo
Journal:  Genome Res       Date:  2010-07-19       Impact factor: 9.043

3.  VarScan 2: somatic mutation and copy number alteration discovery in cancer by exome sequencing.

Authors:  Daniel C Koboldt; Qunyuan Zhang; David E Larson; Dong Shen; Michael D McLellan; Ling Lin; Christopher A Miller; Elaine R Mardis; Li Ding; Richard K Wilson
Journal:  Genome Res       Date:  2012-02-02       Impact factor: 9.043

4.  Next-Generation Sequencing Analysis and Algorithms for PDX and CDX Models.

Authors:  Garima Khandelwal; María Romina Girotti; Christopher Smowton; Sam Taylor; Christopher Wirth; Marek Dynowski; Kristopher K Frese; Ged Brady; Caroline Dive; Richard Marais; Crispin Miller
Journal:  Mol Cancer Res       Date:  2017-04-25       Impact factor: 5.852

5.  Rare mutations of the PIK3CA gene in malignancies of the hematopoietic system as well as endometrium, ovary, prostate and osteosarcomas, and discovery of a PIK3CA pseudogene.

Authors:  Claudia I Müller; Carl W Miller; Wolf-K Hofmann; Mitchell E Gross; Christine S Walsh; Norihiko Kawamata; Quang T Luong; H Phillip Koeffler
Journal:  Leuk Res       Date:  2006-06-09       Impact factor: 3.156

6.  Integrative Genomics Viewer (IGV): high-performance genomics data visualization and exploration.

Authors:  Helga Thorvaldsdóttir; James T Robinson; Jill P Mesirov
Journal:  Brief Bioinform       Date:  2012-04-19       Impact factor: 11.622

7.  Distant metastasis occurs late during the genetic evolution of pancreatic cancer.

Authors:  Shinichi Yachida; Siân Jones; Ivana Bozic; Tibor Antal; Rebecca Leary; Baojin Fu; Mihoko Kamiyama; Ralph H Hruban; James R Eshleman; Martin A Nowak; Victor E Velculescu; Kenneth W Kinzler; Bert Vogelstein; Christine A Iacobuzio-Donahue
Journal:  Nature       Date:  2010-10-28       Impact factor: 49.962

8.  Consensus rules in variant detection from next-generation sequencing data.

Authors:  Peilin Jia; Fei Li; Jufeng Xia; Haiquan Chen; Hongbin Ji; William Pao; Zhongming Zhao
Journal:  PLoS One       Date:  2012-06-08       Impact factor: 3.240

9.  Xenome--a tool for classifying reads from xenograft samples.

Authors:  Thomas Conway; Jeremy Wazny; Andrew Bromage; Martin Tymms; Dhanya Sooraj; Elizabeth D Williams; Bryan Beresford-Smith
Journal:  Bioinformatics       Date:  2012-06-15       Impact factor: 6.937

10.  Quantitation of Murine Stroma and Selective Purification of the Human Tumor Component of Patient-Derived Xenografts for Genomic Analysis.

Authors:  Valentina E Schneeberger; Viola Allaj; Eric E Gardner; J T Poirier; Charles M Rudin
Journal:  PLoS One       Date:  2016-09-09       Impact factor: 3.240

View more
  2 in total

1.  Ancestral characterization of 1018 cancer cell lines highlights disparities and reveals gene expression and mutational differences.

Authors:  Michael D Kessler; Nicholas W Bateman; Thomas P Conrads; George L Maxwell; Julie C Dunning Hotopp; Timothy D O'Connor
Journal:  Cancer       Date:  2019-03-13       Impact factor: 6.860

2.  Translesion DNA synthesis mediates acquired resistance to olaparib plus temozolomide in small cell lung cancer.

Authors:  Marcello Stanzione; Jun Zhong; Edmond Wong; Thomas J LaSalle; Jillian F Wise; Antoine Simoneau; David T Myers; Sarah Phat; Moshe Sade-Feldman; Michael S Lawrence; M Kyle Hadden; Lee Zou; Anna F Farago; Nicholas J Dyson; Benjamin J Drapkin
Journal:  Sci Adv       Date:  2022-05-13       Impact factor: 14.957

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.